BIO

Bio-Rad Laboratories, Inc.

Technology
388.51 +7.55 +1.98% Pre-Market
2026-09-02 • USD

Key Metrics

Market Cap 10.39B
EV 9.74B
Shares Out 26.81M
Revenue (ttm) 2.59B
Net Income 222.40M
Beta —
P/E —
Forward P/E —
EPS (ttm) $8.19
P/S 4.01
P/B 1.45
P/FCF 29.43
P/C 21.09
EV/Sales 3.76
EV/EBITDA 44.59
ROA 2.17%
ROE 3.11%
ROIC 0.41%
Gross Margin 51.9%
Oper. Margin 2.05%
Profit Margin 8.59%
Debt/Eq 0.14
LT Debt/Cap 10.07%
Quick Ratio 2.14
Current Ratio 3.14
Book/sh 268.22
Cash/sh 19.33
Div Yield —
Div TTM —
Payout Ratio —
SMA20 4.89%
SMA50 16.92%
SMA200 28.98%
Volume 285,327
Avg Volume 356.64K
Rel Volume 0.8
Perf Week -2.30%
Perf Month 13.82%
Perf Quarter 24.97%
Perf Half Y 35.96%
Perf YTD 25.73%
Perf Year 32.25%
Perf 3Y -3.46%
Perf 5Y -53.52%

Factor Lens

Seasonal Performance

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

Bio-Rad Laboratories, Inc. is a multinational life science and clinical diagnostics company that develops, manufactures, and markets a broad portfolio of instruments, systems,…

Name
Bio-Rad Laboratories, Inc.
Industry
Technology
CEO
Norman Schwartz · Chief Executive Officer and Chairman of the Board
Employees
7,450 as of 2025-12-31
IPO Date
2011-06-15
Phone
(510) 724-7000
Address
1000 Alfred Nobel Drive, Hercules, CA 94547
Website
www.bio-rad.com

Key Executives

Name Title FY Pay
Arnold A. Pinkston Director —
Melinda Litherland Director —
Gregory K. Hinckley Director —
Jeffrey L. Edwards Director —
Norman Schwartz Chief Executive Officer and Chairman of the Board —

Latest News

Related stocks

Other companies in the same sector on MarketWalks.